76 million

By the end of 2015, Gavi had contributed to immunising 76 million children against pneumococcal disease. Gavi surpassed its 2015 target of 45 introductions already in 2014 – more than one year ahead of schedule. More than three-quarters of all Gavi-supported countries have introduced the vaccine.

Source: WHO/UNICEF 2016

Every two minutes

One woman dies from cervical cancer every two minutes – or 266,000 a year – over 85% in the developing world. If current trends hold, and without changes in prevention and control, cervical cancer deaths could eventually outpace maternal deaths. Two-thirds of all cervical cancer deaths can be prevented with the human papillomavirus (HPV) vaccine.

Source: WHO

19 million

19 million infants remain under-immunised with three doses of DTP in the world each year. Almost one in five of all children in Gavi-supported countries miss out on a full course of this basic package of vaccines.

Source: WHO/UNICEF 2016

1.5 million

In 2012, approximately 6.6 million children died before the age of five. WHO estimates that 1.5 million of these deaths are due to vaccine-preventable diseases.

Source: WHO

44%

The weighted average price of pentavalent vaccine per dose dropped 44% from US$ 2.98 in 2010 to US$ 1.68 in 2015, and is expected to decrease further to US$ 0.79 by 2019.

Source: Gavi

US$ 1 = US$ 18

A study in Health Affairs covering 73 Gavi-supported countries over the 2011–2020 period shows that, for every US$ 1 spent on immunisation, US$ 18 are saved in healthcare costs, lost wages and lost productivity due to illness. If we take into account the broader benefits of people living longer, healthier lives, the return on investment rises to US$ 48 per US$ 1 spent.

Source: Ozawa S, Clark S, Portnoy A et al. Return on investment from childhood immunizations in low- and middle-income countries, 2011-20, Health Affairs 2016.

Close to 580 million

Since 2000, Gavi support has contributed to the immunisation of close to 580 million children.

Source: WHO/UNICEF 2016

95%

Over 95% of children in Gavi-supported countries do not yet have access to all 11 vaccines recommended by WHO for infants in all countries.

Source: WHO/UNICEF

>8 million

Since its inception in 2000, Gavi has helped developing countries to prevent more than 8 million future deaths through its support to 10 vaccines: pentavalent, pneumococcal, rotavirus, yellow fever, meningitis A, Japanese encephalitis, HPV, measles second dose, measles-rubella and rubella.

Source: Gavi/Bill & Melinda Gates Foundation 2016

20 by 2020

Gavi continues to help countries to build sustainable immunisation programmes. Nine countries have already started to fully self-finance all their vaccines introduced with Gavi funding. By the end of 2020, a total of 20 countries are expected to have transitioned out of our support.

Source: Gavi

235 million

By the end of 2015, 16 countries in the African meningitis belt had collectively immunised 235 million people against meningitis A with support from Gavi.

Source: WHO 2014

close icon

modal window here